Cited by 199Epilepsy research and treatmentIon channel regulation and functionCardiac electrophysiology and arrhythmias

A Nonsense Mutation of the Sodium Channel Gene SCN2A in a Patient with Intractable Epilepsy and Mental Decline

Open access
Kamiya, Kazusaku, Kaneda, Makoto, Sugawara, Takashi, Mazaki, Emi, Okamura, Nami, Montal, Mauricio, Makita, Naomasa, Tanaka, Masaki +4 more·2004·The Journal of Neuroscience

Abstract

Mutations, exclusively missense, of voltage-gated sodium channel α subunit type 1 (SCN1A) and type 2 (SCN2A) genes were reported in patients with idiopathic epilepsy: generalized epilepsy with febrile seizures plus. Nonsense and frameshift mutations of SCN1A, by contrast, were identified in intractable epilepsy: severe myoclonic epilepsy in infancy (SMEI). Here we describe a first nonsense mutation of SCN2A in a patient with intractable epilepsy and severe mental decline. The phenotype is similar to SMEI but distinct because of partial epilepsy, delayed onset (1 year 7 months), and absence of temperature sensitivity. A mutational analysis revealed that the patient had a heterozygous de novo nonsense mutation R102X of SCN2A. Patch-clamp analysis of Na v 1.2 wild-type channels and the R102X mutant protein coexpressed in human embryonic kidney 293 cells showed that the truncated mutant protein shifted the voltage dependence of inactivation of wild-type channels in the hyperpolarizing direction. Analysis of the subcellular localization of R102X truncated protein suggested that its dominant negative effect could arise from direct or indirect cytoskeletal interactions of the mutant protein. Haploinsufficiency of Na v 1.2 protein is one plausible explanation for the pathology of this patient; however, our biophysical findings suggest that the R102X truncated protein exerts a dominant negative effect leading to the patient's intractable epilepsy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.3089-03.2004

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • SCN2A is the second strongest overall association, with two truncating mutations in ASD cases and three in ID cases.

    “The second strongest overall association, with two truncating mutations in ASD cases and three such mutations in ID cases, is SCN2A, a gene previously associated with epilepsy and seizure disorders [52,53].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kamiya, K., Kaneda, M., Sugawara, T., Mazaki, E., Okamura, N., Montal, M., Makita, N., Tanaka, M., Fukushima, K., Fujiwara, T., Inoue, Y., & Yamakawa, K.
Affiliations
  • RIKEN (JP)
  • Keio University (JP)
  • University of California San Diego (US)
  • Hokkaido University (JP)
  • RIKEN Center for Brain Science (JP)
  • National Epilepsy Center (JP)
Corresponding author
Yamakawa, Kazuhiro
Venue
The Journal of Neuroscience
Published
2004-03-17
Volume
24
Issue
11
Pages
2690-2698
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W2096680774
Cited by
199
References
49
Citations by year
2026: 2 · 2025: 5 · 2024: 1 · 2023: 7 · 2022: 5 · 2021: 10 · 2020: 7 · 2019: 13 · 2018: 10 · 2017: 9 · 2016: 9 · 2015: 11 · 2014: 20 · 2013: 11 · 2012: 10
FWCI
6.22
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Keio University
  • National Institutes of Health
  • RIKEN
  • National Institute of General Medical Sciences (GM-49711, R01GM049711)
  • RIKEN Brain Science Institute
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Epilepsy research and treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords
SCN2A, nonsense mutation, drug-resistant epilepsy, intellectual disability, Dravet syndrome, de novo mutations, dominant negative effect, haploinsufficiency, voltage-gated sodium channels, voltage-dependent inactivation, subcellular localization, cytoskeletal interactions, focal epilepsy
MeSH terms
Adult, Autistic Disorder, Cell Line, DNA Mutational Analysis, Electroencephalography, Epilepsy, Female, Genes, Dominant, Humans, Hyperkinesis, Kidney, Intellectual Disability, Nerve Tissue Proteins, Pedigree, Transfection, Sodium Channels, Gene Expression, Codon, Nonsense, Patch-Clamp Techniques, Protein Subunits, NAV1.2 Voltage-Gated Sodium Channel

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review